Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 12:00 PM CET
Settings

Settings

Goto Application

1. WO2022010337 - METHOD FOR REDUCING THE INCIDENCE AND PREVALENCE OF HUMAN PAPILLOMAVIRUS (HPV) AND FOR PROVIDING PROTECTION AGAINST SEXUALLY TRANSMITTED INFECTIONS

Publication Number WO/2022/010337
Publication Date 13.01.2022
International Application No. PCT/MX2021/000022
International Filing Date 05.07.2021
IPC
A61K 33/24 2019.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
Applicants
  • SANDERS ESPARZA, Eleonora [MX]/[MX]
  • SANDERS ESPARZA, Bárbara [MX]/[MX]
Inventors
  • SANDERS ESPARZA, Eleonora
  • SANDERS ESPARZA, Bárbara
Agents
  • SANDERS ESPARZA, María Fernanda
Priority Data
16/921,36006.07.2020US
MX/a/2020/00877821.08.2020MX
Publication Language Spanish (es)
Filing Language Spanish (ES)
Designated States
Title
(EN) METHOD FOR REDUCING THE INCIDENCE AND PREVALENCE OF HUMAN PAPILLOMAVIRUS (HPV) AND FOR PROVIDING PROTECTION AGAINST SEXUALLY TRANSMITTED INFECTIONS
(ES) MÉTODO PARA REDUCIR LA INCIDENCIA Y PREVALENCIA DEL VIRUS DEL PAPILOMA HUMANO (VPH) Y PARA PROPORCIONAR PROTECCIÓN CONTRA INFECCIONES DE TRANSMISIÓN SEXUAL
(FR) PROCÉDÉ POUR RÉDUIRE L'INCIDENCE ET LA PRÉVALENCE DU VIRUS DU PAPILLOME HUMAIN (VPH) ET FOURNIR UNE PROTECTION CONTRE DES INFECTIONS SEXUELLEMENT TRANSMISSIBLES
Abstract
(EN) Methods comprising the insertion of a uterine cervical device in the lower part of the uterine cavity and endocervix to reduce the incidence of human papillomavirus, mainly types 16 and 18, in women, thereby preventing the development of uterine cervical cancer; to modify the cervical microbiota; to increase leukocytes; and to protect women against sexually transmitted infections.
(ES) Métodos que comprenden la inserción de un dispositivo cervical uterino en la parte inferior de la cavidad uterina y endocérvix para disminuir la incidencia del virus del papiloma humano en mujeres, principalmente los tipos 16 y 18, impidiendo de este modo el desarrollo de cáncer cervical uterino; para modificar la microbiota cervical; para incrementar los leucocitos y proteger contra las infecciones de transmisión sexual en las mujeres.
(FR) L'invention concerne des procédés comprenant l'insertion d'un dispositif cervical utérin dans la partie inférieure de la cavité utérine et de l'endocol pour diminuer l'incidence du virus du papillome humain chez les femmes, principalement les types 16 et 18, empêchant ainsi le développement de cancer cervical utérin, pour modifier le microbiote cervical, pour augmenter les leucocytes et protéger contre les infections sexuellement transmissibles chez les femmes.
Latest bibliographic data on file with the International Bureau